Nazha, A <br/><br/>
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.  [electronic resource] 

 -  Leukemia  12 2017 
 - 2848-2850 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2017.266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Middle Aged<br/>Mutation<br/>Myelodysplastic Syndromes--drug therapy<br/>Prognosis<br/>Young Adult